SectorBiological Technology
Established Date--
Listing Date23/10/2020
ExchangeNASDAQ Stock Exchange
Full-time Employees106
Fiscal Year Ends31/12
Security TypeCommon stock
Office address99 Coolidge Avenue, Suite 500, Watertown, Massachusetts 02472
Business
IntroductionFoghorn Therapeutics Inc., was incorporated in October 2015 as a Delaware corporation. The company is a clinical-stage precision therapy biotechnology company that is the first to develop a new class of drugs that target chromatin regulation systems to correct abnormal gene expression. Its proprietary Gene Traffic Control platform enables integrated research and targeting of the system, and its R&D pipeline focuses on oncology with potential applications in other disease areas.
